Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | CA12 | O43570 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.36 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.36 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.36 |
| ▸ | IKZF3 | Q9UKT9 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29619427 | 1.00 | L3MBTL1 (0.43) | L3MBTL1TSHRGAALMNAKMT2A | |
| SCHEMBL26088195 | 1.00 | L3MBTL1 (0.43) | L3MBTL1TSHRGAALMNAKMT2A | |
| SCHEMBL29928122 | 1.00 | L3MBTL1 (0.43) | L3MBTL1TSHRGAALMNAKMT2A | |
| SCHEMBL26086405 | 0.82 | TSHR (0.44) | L3MBTL1TSHRGAALMNAKMT2A | |
| SCHEMBL23819703 | 0.82 | TSHR (0.44) | L3MBTL1TSHRGAALMNAKMT2A | |
| SCHEMBL31141354 | 0.82 | TSHR (0.44) | L3MBTL1TSHRGAALMNAKMT2A | |
| SCHEMBL5316161 | 0.79 | MEN1 (0.42) | L3MBTL1TSHRGAALMNAKMT2A | |
| SCHEMBL24358382 | 0.78 | L3MBTL1 (0.42) | L3MBTL1TSHRGAALMNAKMT2A | |
| SCHEMBL26088300 | 0.77 | L3MBTL1 (0.43) | L3MBTL1TSHRGAALMNAKMT2A | |
| SCHEMBL26088296 | 0.77 | L3MBTL1 (0.43) | L3MBTL1TSHRGAALMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4117780-B1 | MODULATORS OF THE INTEGRATED STRESS RESPONSE PATHWAY | EVOTEC INT GMBH (DE) | 2026-05-06 | — | — | EP | disclosed |
| US-12441720-B2 | Modulators of the integrated stress response pathway | EVOTEC INTERNATIONAL GMBH (DE) | 2025-10-14 | — | — | US | disclosed |
| US-20230391763-A1 | MODULATORS OF THE INTEGRATED STRESS RESPONSE PATHWAY | EVOTEC INTERNATIONAL GMBH (DE) | 2023-12-07 | — | — | US | disclosed |
| CN-116761803-A | Modulators of integrated stress response pathways | 埃沃特克国际有限责任公司 | 2023-09-15 | — | — | CN | disclosed |
| US-20230129907-A1 | MODULATORS OF THE INTEGRATED STRESS RESPONSE PATHWAY | EVOTEC INTERNATIONAL GMBH (DE) | 2023-04-27 | — | — | US | disclosed |
| US-20230129907-A1 | MODULATORS OF THE INTEGRATED STRESS RESPONSE PATHWAY | EVOTEC INTERNATIONAL GMBH (DE) | 2023-04-27 | — | — | US | disclosed |
| US-20230129907-A1 | MODULATORS OF THE INTEGRATED STRESS RESPONSE PATHWAY | EVOTEC INTERNATIONAL GMBH (DE) | 2023-04-27 | — | — | US | disclosed |
| CN-115190813-A | Modulators of integrated stress response pathways | 埃沃特克国际有限责任公司 | 2022-10-14 | — | — | CN | disclosed |
| WO-2022084447-A1 | MODULATORS OF THE INTEGRATED STRESS RESPONSE PATHWAY | EVOTEC INTERNATIONAL GMBH (DE) | 2022-04-28 | — | — | WO | disclosed |
| WO-2021180774-A1 | MODULATORS OF THE INTEGRATED STRESS RESPONSE PATHWAY | EVOTEC INTERNATIONAL GMBH (DE) | 2021-09-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230391763-A1 | MODULATORS OF THE INTEGRATED STRESS RESPONSE PATHWAY | CRH, AVPR1B, CRHR2 | L3MBTL1 1971/4885TSHR 672/4885GAA 3152/4885 |
| US-20230129907-A1 | MODULATORS OF THE INTEGRATED STRESS RESPONSE PATHWAY | CRHR2, CRHR1, CRH | L3MBTL1 2133/4885TSHR 621/4885GAA 3158/4885 |
| US-12441720-B2 | Modulators of the integrated stress response pathway | CRHR2, CRHR1, CRH | L3MBTL1 2133/4885TSHR 621/4885GAA 3158/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.